915,867 Shares in Cronos Group Inc. $CRON Bought by Oasis Management Co Ltd.

Oasis Management Co Ltd. bought a new position in Cronos Group Inc. (NASDAQ:CRON) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 915,867 shares of the company’s stock, valued at approximately $2,409,000. Oasis Management Co Ltd. owned 0.24% of Cronos Group as of its most recent SEC filing.

A number of other large investors also recently added to or reduced their stakes in CRON. Octavia Wealth Advisors LLC purchased a new position in Cronos Group in the 4th quarter worth $28,000. Brooklyn Investment Group raised its position in Cronos Group by 5,733.0% in the 3rd quarter. Brooklyn Investment Group now owns 10,966 shares of the company’s stock worth $30,000 after purchasing an additional 10,778 shares during the period. Valeo Financial Advisors LLC purchased a new position in Cronos Group in the 4th quarter worth $30,000. Swiss Life Asset Management Ltd purchased a new position in Cronos Group in the 3rd quarter worth $31,000. Finally, Scientech Research LLC purchased a new position in Cronos Group in the 3rd quarter worth $32,000. Hedge funds and other institutional investors own 8.71% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently commented on CRON. TD Securities reiterated a “buy” rating on shares of Cronos Group in a research report on Tuesday, May 12th. Weiss Ratings reissued a “sell (d+)” rating on shares of Cronos Group in a report on Friday, May 29th. Finally, Wall Street Zen raised shares of Cronos Group from a “hold” rating to a “buy” rating in a report on Saturday, May 16th. Two analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Cronos Group currently has a consensus rating of “Hold” and an average target price of $2.30.

Cronos Group Stock Down 2.5%

Shares of Cronos Group stock opened at $2.68 on Friday. The firm has a market cap of $999.72 million, a PE ratio of 268.27 and a beta of 0.89. Cronos Group Inc. has a 12-month low of $1.84 and a 12-month high of $3.43. The company’s fifty day simple moving average is $2.68 and its two-hundred day simple moving average is $2.65.

Cronos Group (NASDAQ:CRON) last announced its quarterly earnings results on Monday, May 11th. The company reported $0.01 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.01. The business had revenue of $58.97 million for the quarter, compared to analyst estimates of $42.20 million. Cronos Group had a negative net margin of 1.14% and a negative return on equity of 1.26%. As a group, sell-side analysts expect that Cronos Group Inc. will post 0.07 earnings per share for the current fiscal year.

Cronos Group Company Profile

Cronos Group Inc is a Canadian cannabinoid company dedicated to the cultivation, production and distribution of cannabis and cannabidiol (CBD) products for both medical and adult-use markets. Headquartered in Toronto, Ontario, the company manages operations that span the full cannabis value chain, including breeding, greenhouse cultivation, extraction, product formulation and packaging. Cronos Group’s business model emphasizes innovation in product development and scalability in manufacturing to meet evolving regulatory and consumer demands.

The company’s branded portfolio includes Peace Naturals, which focuses on pharmaceutical-grade medical cannabis; Spinach, a line of adult-use cannabis oils and tinctures; and Cove, a range of wellness-oriented CBD offerings.